Clinical Advances in Atopic Dermatitis From EADV 2021 Clinical Advances in Atopic Dermatitis From EADV 2021

Advances in atopic dermatitis from EADV 2021 include monoclonal antibodies targeting OX40, symptom control with ruxolitinib cream, and benefits of delgocitinib cream, as discussed by Prof Alan Irvine.Medscape

Source: Medscape Today Headlines - October 20, 2021 Category: Consumer Health News Tags: None ReCAP Source Type: news